Seeking Alpha
  • Michael Bryant
    Bristol-Myers (BMY) agreed to buy Inhibitex (INHX) for $2.5 billion, but INHX's market cap is still $1.85 billion. http://reut.rs/xkAV9Z
    1/9/12
    Reply